---
title: "Sinopharm Accord (200028.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/200028.SZ/norm.md"
symbol: "200028.SZ"
name: "Sinopharm Accord"
parent: "https://longbridge.com/en/quote/200028.SZ.md"
datetime: "2026-03-04T22:57:18.547Z"
locales:
  - [en](https://longbridge.com/en/quote/200028.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/200028.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/200028.SZ/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/200028.SZ/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/200028.SZ/norm.md)


# Sinopharm Accord (200028.SZ) — Financial Reports

## Income Statement (HKD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.5684 | 0.6677 | 0.6319 | -0.8191 | 0.6330 |
| ROE | 6.37% | 7.48% | 7.36% | -9.46% | 7.18% |
| Revenue | 20.04B | 20.25B | 19.59B | 19.06B | 20.71B |
| Net income | 318.34M | 369.85M | 351.28M | -450.06M | 356.98M |
| Operating income | 481.81M | 487.29M | 421.05M | 256.19M | 455.00M |
| Gross margin | 10.18% | 10.92% | 10.34% | 11.49% | 10.79% |
| Net margin | 1.59% | 1.83% | 1.79% | -2.36% | 1.72% |
| Profit quality | -92.18% | 24.30% | -21.63% | 12.10% | 116.71% |

## Balance Sheet (HKD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 55.27B | 55.19B | 53.57B | 50.59B | 57.62B |
| Leverage | 2.35 | 2.37 | 2.37 | 2.29 | 2.40 |
| BVPS | 36.20 | 35.67 | 34.63 | 33.77 | 36.05 |
| Turnover | 1.42 | 1.44 | 1.45 | 1.56 | 1.47 |
| Cash & STI | 6.17B | 7.44B | 5.94B | 7.88B | 6.02B |
| Inv & Rec | 9.12B | 8.83B | 8.59B | 7.88B | 9.30B |
| LT assets | 3.19B | 3.37B | 3.57B | 3.70B | 4.17B |
| Net debt | -281.53M | -31.87M | 459.16M | -1.78B | 1.62B |

## Cash Flow Statement (HKD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -522.69M | 2.01B | -1.95B | 2.12B | 389.86M |
| Investing CF | -14.22M | -4.52M | -64.20M | -84.53M | 108.82M |
| Financing CF | -711.67M | -826.26M | 98.60M | 164.88M | -1.04B |
| Free CF | -864.63M | 1.17B | -2.51B | 4.87B | -917.69M |
| OCF coverage | 493.34% | 129.71% | -471.15% | 112.20% | -123.74% |
| Repaid & issued | 521.52M | 417.63M | 682.71M | 610.25M | -146.56M |
| CapEx | -64.24M | -54.83M | -68.87M | -84.42M | -71.13M |

## Distribution Plan

**Dividend Yield**: 2.94

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.366CNY | 2025-06-27 | 2025-06-25 | 2025-06-27 |
| Cash Dividend: 
0.68CNY | 2024-06-27 | 2024-06-25 | 2024-06-27 |
| Cash Dividend: 
0.8CNY. 
Share conversation: 0.3 for 1 | 2023-06-05 | 2023-06-01 | 2023-06-05 |